Quantcast

Latest National Institute for Health and Clinical Excellence Stories

2008-08-28 00:00:37

By JULIA BRADSHAW People who face going blind will now have access to a sight- saving drug on the NHS following a massive campaign to make the medication more widely available. The National Institute for Health and Clinical Excellence has today published guidelines instructing primary care trusts in England and health boards in Wales to fund the drug Lucentis for patients who have wet age- related macular degeneration in either eye. But patients across Devon have already been...

2008-08-27 06:00:48

By Mike Waites Health Correspondent The National Institute for Clinical Excellence (Nice) has backed NHS treatment using the drug Lucentis for the devastating eye condition wet age-related macular degeneration (AMD) following a two- and-half-year battle by patients.The Yorkshire Post revealed last month that people affected by the condition in the region are already being treated using the drug but the decision means the national postcode lottery of care will now end.The disease is the...

2008-08-27 00:00:44

By Jane Kirby Thousands OF people with a devastating eye disease could have their sight saved by a new drug being made available on the NHS, under guidelines published today. The National Institute for Health and Clinical Excellence (Nice) has recommended the drug Lucentis, which is already approved in Scotland, after performing a u-turn on draft guidance published last year. The move was welcomed by the Royal National Institute for the Blind (RNIB), which has campaigned for Lucentis...

2008-08-26 18:00:48

By Emma Brady Midlands cancer patients are being kept in the dark about new treatments that could extend their lives, it was claimed today. One in four myeloma specialists questioned in a survey admitted hiding facts about new treatments that may be tough to obtain on the NHS, citing the main reason was to avoid upsetting or confusing patients. The Myeloma UK poll comes less than three weeks after the National Institute for health and Clinical Excellence (Nice) issued draft guidance...

2008-08-26 18:00:00

By John von Radowitz DOCTORS are keeping cancer patients in the dark about new treatments that could extend their lives, it was claimed today. A quarter of myeloma specialists questioned in a survey admitted hiding the facts about treatments that may be difficult to obtain on the NHS. The main reason given was to avoid distressing or confusing patients. Myeloma is a bone marrow cancer that affects around 3,800 people each year in the UK. Of these, 2,600 are likely to die from the...

2008-08-26 03:00:56

A Cautious welcome has been given to a pledge by Assembly Health Minister Edwina Hart to call on her officials to ensure Welsh rheumatoid arthritis patients get effective treatment. Jenny Randerson, Lib Dem Assembly health spokeswoman, said she was pleased with the vow after flagging up concerns about new guidance on limiting drug treatments to "one go only". Although a number of drugs are on offer to deal with the condition, the draft guidance from Nice (the National Institute for...

2008-08-25 09:00:26

Leading UK cancer experts have accused a health watchdog of forcing patients to remortgage their homes to afford treatments freely available in Europe. The group of 26 professors were "dismayed" at guidance issued by the National Institute for Health and Clinical Excellence (Nice) to deny patients four vital kidney cancer drugs on the NHS. They said the decision showed it was time for a "radical change" in how the NHS makes decisions on what treatments are available for cancer sufferers....

2008-08-25 09:00:26

By Nicola Fenwick CANCER experts have accused a health watchdog of forcing patients to remortgage their homes to pay for treatments freely available in Europe. The group of 26 professors are dismayed at guidance issued by the National Institute for Health and Clinical Excellence (Nice) that deny four kidney cancer drugs on the NHS. Earlier this month, Nice said the drugs + Sutent (sunitinib), Avastin (bevacizumab), Nexavar (sorafenib) and Torisel (temsirolimus) ? were not...

2008-08-24 22:57:41

Home News IN BRIEF *Cancer patients are being forced by a health watchdog to remortgage their homes to pay for treatments freely availably elsewhere in Europe, a group of 26 professors said yesterday. The experts said they were "dismayed" by the National Institute for Health and Clinical Excellence's guidance denying patients four kidney cancer drugs on the NHS and called for "radical change". (c) 2008 Independent, The; London (UK). Provided by ProQuest LLC. All rights Reserved.

2008-08-21 06:01:02

Research and Markets (http://www.researchandmarkets.com/research/7c95b2/pharmaceutical_pri) has announced the addition of Decision Resources, Inc.'s new report "Pharmaceutical Pricing and Reimbursement News in the Second Quarter of 2008" to their offering. The United States stands in stark contrast to Europe and Japan in terms of the freedom that manufacturers have to set--and increase--the prices of branded drugs in the U S market. However, pharmaceutical companies need to give careful...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related